These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 18949995

  • 1. [Practical approach to hypereosinophilia].
    Roufosse F, Cogan E.
    Rev Med Brux; 2008 Sep; 29(4):400-8. PubMed ID: 18949995
    [Abstract] [Full Text] [Related]

  • 2. Hypereosinophilic syndromes.
    Roufosse FE, Goldman M, Cogan E.
    Orphanet J Rare Dis; 2007 Sep 11; 2():37. PubMed ID: 17848188
    [Abstract] [Full Text] [Related]

  • 3. Current strategies in the management of hypereosinophilic syndrome, including mepolizumab.
    Schwartz LB, Sheikh J, Singh A.
    Curr Med Res Opin; 2010 Aug 11; 26(8):1933-46. PubMed ID: 20565230
    [Abstract] [Full Text] [Related]

  • 4. [The hypereosinophilic syndrome: case report].
    Mikołajczyk K, Zaba R, Walkowiak B, Grzybowski G, Samborski W.
    Ann Acad Med Stetin; 2006 Aug 11; 52 Suppl 2():65-9. PubMed ID: 17471838
    [Abstract] [Full Text] [Related]

  • 5. Hypereosinophilic syndrome: diagnosis and treatment.
    Peros-Golubicić T, Smojver-Jezek S.
    Curr Opin Pulm Med; 2007 Sep 11; 13(5):422-7. PubMed ID: 17940488
    [Abstract] [Full Text] [Related]

  • 6. [Diagnostic approach to hypereosinophilia].
    Granel B, Serratrice J, Schleinitz N, Veit V, Swiader L, Disdier P, Harle JR, Dessein A, Weiller PJ.
    Med Trop (Mars); 1998 Sep 11; 58(4 Suppl):489-92. PubMed ID: 10410372
    [Abstract] [Full Text] [Related]

  • 7. [Idiopathic hypereosinophilic syndrome: toward a new molecular-targeted therapy and a new cytomorphological and molecular definition].
    Moles MP, Landry J, Roche-Lestienne C, Godon A, Schmidt-Tanguy A, Gardembas M, Le Clech C, Verret JL, Zandecki M, Blanchet O.
    Ann Biol Clin (Paris); 2005 Sep 11; 63(3):317-22. PubMed ID: 15951264
    [Abstract] [Full Text] [Related]

  • 8. Treatment of idiopathic hypereosinophilic syndrome with imatinib mesylate.
    Garg A, Duggal L, Aggarwal S, Jain N.
    J Assoc Physicians India; 2006 Nov 11; 54():883-6. PubMed ID: 17249259
    [Abstract] [Full Text] [Related]

  • 9. Eosinophilia: secondary, clonal and idiopathic.
    Tefferi A, Patnaik MM, Pardanani A.
    Br J Haematol; 2006 Jun 11; 133(5):468-92. PubMed ID: 16681635
    [Abstract] [Full Text] [Related]

  • 10. Anti-IL-5 and hypereosinophilic syndromes.
    Sutton SA, Assa'ad AH, Rothenberg ME.
    Clin Immunol; 2005 Apr 11; 115(1):51-60. PubMed ID: 15870021
    [Abstract] [Full Text] [Related]

  • 11. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
    Gotlib J.
    Am J Hematol; 2014 Mar 11; 89(3):325-37. PubMed ID: 24577808
    [Abstract] [Full Text] [Related]

  • 12. [Hematological disorders and hypereosinophilias].
    Malfuson JV, Fagot T, Konopacki J, Mangouka L, Souleau B, de Revel T.
    Rev Med Interne; 2009 Apr 11; 30(4):322-30. PubMed ID: 19201511
    [Abstract] [Full Text] [Related]

  • 13. Hypereosinophilic syndrome: an update.
    Wilkins HJ, Crane MM, Copeland K, Williams WV.
    Am J Hematol; 2005 Oct 11; 80(2):148-57. PubMed ID: 16184589
    [Abstract] [Full Text] [Related]

  • 14. Clinical management of the hypereosinophilic syndromes.
    Cogan E, Roufosse F.
    Expert Rev Hematol; 2012 Jun 11; 5(3):275-89; quiz 290. PubMed ID: 22780208
    [Abstract] [Full Text] [Related]

  • 15. Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate.
    Schaller JL, Burkland GA.
    MedGenMed; 2001 Sep 07; 3(5):9. PubMed ID: 11698916
    [Abstract] [Full Text] [Related]

  • 16. [Hypereosinophilia: focus on clinical aspects].
    Cogan E.
    Rev Med Brux; 1994 Sep 07; 15(2):55-60. PubMed ID: 8029573
    [Abstract] [Full Text] [Related]

  • 17. Treatment of patients with the hypereosinophilic syndrome with mepolizumab.
    Rothenberg ME, Klion AD, Roufosse FE, Kahn JE, Weller PF, Simon HU, Schwartz LB, Rosenwasser LJ, Ring J, Griffin EF, Haig AE, Frewer PI, Parkin JM, Gleich GJ, Mepolizumab HES Study Group.
    N Engl J Med; 2008 Mar 20; 358(12):1215-28. PubMed ID: 18344568
    [Abstract] [Full Text] [Related]

  • 18. Treatment of a case of pediatric hypereosinophilic syndrome with anti-interleukin-5.
    Mehr S, Rego S, Kakakios A, Kilham H, Kemp A.
    J Pediatr; 2009 Aug 20; 155(2):289-91. PubMed ID: 19619754
    [Abstract] [Full Text] [Related]

  • 19. Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinib.
    Hofmann SC, Technau K, Müller AM, Lübbert M, Bruckner-Tuderman L.
    J Am Acad Dermatol; 2007 May 20; 56(5 Suppl):S68-72. PubMed ID: 17097375
    [Abstract] [Full Text] [Related]

  • 20. The hypereosinophilic syndrome and the biology of cancer.
    Schwartz RS.
    N Engl J Med; 2003 Mar 27; 348(13):1199-200. PubMed ID: 12660383
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.